In our study, CHIP was defined when an individual harbored at least one deleterious insertion/deletion or single nucleotide variant in any of the 74 genes that have been previously linked to myeloid malignancy at a variant allele frequency of at least 2%. Here, STUB1 is linked to myeloid neoplasm.